Abstract
Using in silico docking calculations, NMR analysis of target-ligand binding, and hemolytic activity assays, we searched a 30,000-compound library for an effective inhibitor of tolaasin I, a Pseudomonas tolaasii toxin that causes virulent infection in mushrooms. Of more than 30,000 compounds screened in silico, two compounds were selected. One of these compounds, sorbitololeic acid, bound to tolaasin I and inhibited its hemolytic activity in vitro. Therefore, sorbitololeic acid can be a potential inhibitor of tolaasin I.
Original language | English |
---|---|
Pages (from-to) | 4321-4324 |
Number of pages | 4 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 19 |
Issue number | 15 |
DOIs | |
Publication status | Published - 1 Aug 2009 |
Bibliographical note
Funding Information:This work was supported by grants from the Technology Development Program for Agriculture and Forestry (Agricultural R&D Promotion Center), KRF-2006-005-J03402 (KRF), M10751050003-07N5105-00310 (KOSEF), Biogreen 21 (RDA), and Agenda 11-30-68 (NIAS). Younggiu Lee and Yoonkyung Woo contributed equally to this work.
Keywords
- Hemolytic activity
- In silico docking
- NMR
- Pseudomonas tolaasii
- Tolaasin